Categories AlphaGraphs, Earnings, Finance
GS Earnings: Key highlights from Goldman Sachs Q2 2020 financial results
Goldman Sachs (NYSE: GS) today announced its second quarter financial results for the period ended June 30, 2020.
Net earnings for the second quarter was $2.42 million, or $6.26 per share, compared to net earnings of $2.42 billion, or $5.81 per share in the second quarter of 2019.
Net revenues increased 41% to $13.30 billion.
Provision for credit losses was $1.59 billion, compared to $214 million in the second quarter of 2019.
Our strong financial performance across our client franchises demonstrates the inherent benefits of our diversified business model. The turbulence we have seen in recent months only reinforces our commitment to the strategy we outlined earlier this year to investors. While the economic outlook remains uncertain, I am confident that we will continue to be the firm of choice for clients around the world who are looking to reshape their businesses and rebuild a more resilient economy.
David Solomon, CEO
COVID-19 puts insurers in tricky situation; risks range from litigation to insolvency
Ravaging almost every part of the world and crippling economic activity, the coronavirus pandemic has not spared any business. When it comes to the insurance industry, the nature of impact is complex and there is no doubt the companies will struggle with their underwriting decisions once the damage is fully assessed.
Most Popular
Walmart (WMT) stock research summary | Q3 2021
Walmart (WMT) is a major retailer with a strong presence in the US and international markets. The company offers a wide range of products through its stores and digital channels.
MDB Stock: Is it the right time to invest in MongoDB?
The ongoing information technology boom has spurred the need for effective tools for database management, and enterprises are turning to technology companies like MongoDB Inc. (NASDAQ: MDB) to integrate their
After strong Q3, Thermo Fisher (TMO) expects to end FY21 on a high note
The shares of Thermo Fisher Scientific Inc. (NYSE: TMO), a leading provider of analytical instruments and software, climbed to a record high this week, extending the positive momentum that came
